Kia Carens CNG launched with dealer installed kit

The Kia Carens can be ordered with a dealer installed CNG kit making it Kia’s first CNG-powered model to be on sale in India.  The Carens is CNG available only with Premium (O) variant currently. Prices for the Kia Carens Premium (O) start at Rs 10.99 lakh. The dealer installed CNG kit costs Rs 77,900… Continue reading Kia Carens CNG launched with dealer installed kit

Clean Technica: These Electric Car Batteries Lasting The Longest004224

Support CleanTechnica’s work through a Substack subscription or on Stripe. One of the most common concerns about electric cars from people who haven’t bought one yet (and maybe even from EV owners) is how long the battery will last. Funny enough, a new study from Swedish used car platform Kvdbil finds that EV batteries actually… Continue reading Clean Technica: These Electric Car Batteries Lasting The Longest004224

German FAZ: Over for Segula’s test business010145

The Opel partner Segula will stop operating the test facilities in Rüsselsheim and Rodgau-Dudenhofen, which currently employ around 330 people, on October 31st. Segula Germany boss Holger Jené announced on Monday evening that no investor had been found for the insolvent sub-company Segula Technologies GmbH, in which the Tes business is bundled. The insolvent testing… Continue reading German FAZ: Over for Segula’s test business010145

Ex–Stellantis CEO says Tesla could exit the car industry and may not exist in 10 years: ‘Tesla’s stock market value loss will be colossal’

Car executives once saw Tesla as their industry’s biggest disrupter. But now, at least one former automotive CEO says the company may pull out of the car business, and could even cease to exist within 10 years. Carlos Tavares, who resigned from the top job at Jeep manufacturer Stellantis late last year, said Elon Musk’s… Continue reading Ex–Stellantis CEO says Tesla could exit the car industry and may not exist in 10 years: ‘Tesla’s stock market value loss will be colossal’

BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis

Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across measures of peripheral arthritis, dactylitis, enthesitis, skin psoriasis, and nail psoriasis – indicating sustained inflammation control Sustained clinical response to stringent endpoints in half of patients with axial spondyloarthritis (nr-axSpA and AS): From Week… Continue reading BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis